ptsd | CARLAT PUBLISHING

CLINICAL UPDATE

Advances in Trauma-Focused CBT for Child Sexual Abuse

December 20, 2023

Elisabeth S. Pollio, PhD, Melissa J. McLean, MA, LPC, and Esther Deblinger, PhD

Elisabeth S. Pollio, PhD. Associate Professor of Psychiatry, Rowan-Virtua School of Osteopathic Medicine; Director of Mental Health Administration, Child Abuse Research Education and Service (CARES) Institute. Melissa J. McLean, MA, LPC. Mental Health Clinician, Owner, Morning Joy Counseling, LLC. Esther Deblinger, PhD. Professor of Psychiatry, Rowan-Virtua- School of Osteopathic Medicine; Co-Founder, Child Abuse Education Research and Service (CARES) Institute.

Dr. Pollio and Ms. McLean have no financial relationships with companies related to this material. Dr. Deblinger receives royalties as a speaker and co-developer of Trauma-Focused Cognitive Behavior Therapy (TF-CBT) and as an author from Guilford Publications and Oxford University Press. Relevant financial relationships listed for Dr. Deblinger have been mitigated.

TF-CBT can aid recovery of patients after sexual abuse, making it a recommended and extensively supported therapy for practitioners working with individuals impacted by such trauma.

RESEARCH UPDATE

Can Smoking Marijuana Reduce PTSD Symptoms?

September 1, 2023

Gregory Lande, MD.

Gregory Lande, MD. Dr. Lande, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Many states have passed laws allowing the prescription of cannabis as a treatment for PTSD in spite of the absence of high-quality evidence. In this prospective, double-blinded trial, researchers failed to find evidence that either THC or CBD is an effective treatment for PTSD.

RESEARCH UPDATE

Who Responds to SSRIs in PTSD?

October 30, 2022

Richard Moldawsky, MD

Richard Moldawsky, MD. Dr. Moldawsky has no financial relationships with companies related to this material.

SSRIs are often used in PTSD, but it is not clear that they work for all kinds of trauma. Trials of SSRIs are generally positive in women and people with a history of sexual trauma, while trials involving combat-related trauma tend to be negative. The current study aimed to better identify predictors of response.

Can CBD Work for PTSD?

September 25, 2022

Sin Yan Lo, PMHNP-BC

Sin Yan Lo, PMHNP-BC. Ms. Lo, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Cannabidiol (CBD oil) is a popular self-remedy for anxiety and insomnia. A new study tests the drug in PTSD.

Quetiapine Reconsidered

June 1, 2022

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

It is the best of drugs; it is the worst of drugs. Quetiapine (Seroquel) has a few benefits that are unmatched by other medications, and here we explore where it fits in depression, bipolar, schizophrenia, as well as off-label uses like anxiety and sleep.

MDMA-Assisted Therapy for Severe PTSD

January 31, 2022

Michael Posternak, MD.

Michael Posternak, MD. Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

MDMA is being repurposed as part of drug-assisted psychotherapy for PTSD, and this trial will help determine whether it gains FDA approval for that use.

Minimizing PTSD From Workplace Trauma

January 7, 2022

William Jacobowitz, EdD, RN

William Jacobowitz, EdD, RN. Associate Professor, College of Nursing and Public Health, Adelphi University, Garden City, NY. Mr. Jacobowitz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If you work on a psychiatric inpatient unit, you most likely have witnessed or experienced traumatic events. How can you reduce your or your colleagues’ risk of developing PTSD? Dr. Jacobowitz reviews this important topic.

CLINICAL UPDATE

Using Equine-Assisted Psychotherapy

October 18, 2021

Anja Kriegeskotten, MD, Peter Parry, MBBS, and Renee Sievert, RN, MFT,

Anja Kriegeskotten, MD Psychiatrist in Australia, accredited equine therapist. Peter Parry, MBBS, consultant child and adolescent psychiatrist and senior lecturer at Flinders University in Adelaide, Australia. Renee Sievert, RN, MFT, certified equine therapist, CA. Dr. Kriegeskotten, Dr. Parry, and Ms. Sievert have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Equine therapy is becoming popular for a variety of child and adolescent mental health problems, from ADHD, anxiety disorders and PTSD to developmental challenges. In this article our experts describe the nuts and bolts of equine assisted psychotherapy, covering the research and the practicalities of these approaches.

Light Therapy: Good for What Ails You?

September 28, 2021

Edmund S. Higgins, MD.

Edmund S. Higgins, MD. Clinical associate professor, Psychiatry and Behavioral Sciences, Medical University of South Carolina. Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The health benefits of light therapy are expanding its use beyond winter depression. Here we explore those promises and pitfalls, including ADHD, PTSD, bipolar depression, binge eating, sleep disorders, dementia, sexual dysfunction, traumatic brain injury, diabetes, and arthritis.

Overdiagnosis in Psychiatry

September 10, 2021

Joel Paris, MD

Joel Paris, MD

Professor emeritus at McGill University, and senior psychiatrist and research associate at Sir Mortimer B. Davis-Jewish General Hospital. Dr. Paris is the former editor of the Canadian Journal of Psychiatry and the author of 25 books including Overdiagnosis in Psychiatry, 2nd ed. (Oxford University Press; 2020). Dr. Paris has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Joel Paris explains why adult ADHD, depression, bipolar II, PTSD, and borderline personality are overdiagnosed in psychiatry at the expense of schizophrenia.